RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MORO G
Collezione ASL Biella

Items : 12

Beyond D'Amico risk classes for predicting recurrence after external beam radiotherapy for prostate cancer: the Candiolo classifier. in Radiation oncology (London, England) / Radiat Oncol. 2016 Feb 24;11:23. doi: 10.1186/s13014-016-0599-5.

2016
ASL Torino 4
ASL Biella
ASL Asti
ASL Vercelli

Tessa M; Moro G; Girelli G; Krengli M; Gabriele D; Gabriele P; Garibaldi E; Jereczek-Fossa BA;

Predicting recurrence after 3DC Radiotherapy for prostate cancer: Proposal for a new classifier in Radiotherapy and Oncology

2016
ASL Biella
ASL Torino 4
ASL Asti
ASL VCO

Jereczek-Fossa B; Krengli M; Garibaldi E; Tessa M; Moro G; Girelli G; Bona C; Balcet V; Ferrazza P; Gabriele D;

Early or delayed radiotherapy in high risk prostate cancer patients treated with radical prostatectomy? Long term results of a multicenter prospective study in European Urology, Supplements

2016
ASL Biella

Maurizi F; Antognoni P; Bonetta A; Bonetto EM; Bortolus R; Colombo A; Frezza G; Gabriele P; Giacobazzi P; Marcenaro M; Mattana F; Moro G; Rocchi MBL; Signor M; Malinverni G;

[Unusual osteonecrosis caused by radiochemotherapy. A case]. in La Radiologia medica / Radiol Med. 1999 May;97(5):417-8.

1999
ASL Biella

Ciambellotti E; Moro G;

Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 1998;41(4):333-8. doi: 10.1007/s002800050747.

1998
AOU San Luigi di Orbassano
ASL Biella
ASL Cuneo 2

Dogliotti L; Danese S; Berruti A; Zola P; Buniva T; Bottini A; Richiardi G; Moro G; Farris A; Baù MG; Porcile G;

[Factors affecting the contralateral dose for the non-treated breast in irradiation following quadrantectomy]. in La Radiologia medica / Radiol Med. 1997 May;93(5):596-9.

1997
ASL Biella

Moro G; Ramella S; Bertone A; Maruca S; Stasi M; Ciambellotti E;

Does concomitant chemoradiotherapy influence cosmetic outcome in conservative treatment of breast cancer? in Tumori / Tumori. 1997 Jul-Aug;83(4):743-7. doi: 10.1177/030089169708300406.

1997
ASL Biella

Stasi M; Moro G; Borca VC;

Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survival in Anticancer Research

1997
ASL Cuneo 1
ASL Biella
ASL Cuneo 2
AO Cuneo

Berruti A; Zola P; Buniva T; Baú MG; Farris A; Sarobba MG; Bottin A; Tampellini M; Durando A; Destefanis M; Monzeglio C; Moro G; Sussio M; Perroni D; Dogliotti L;

[Esthetic results of the conservative treatment in breast carcinoma]. in La Radiologia medica / Radiol Med. 1995 Oct;90(4):481-5.

1995
ASL Biella

Moro G;

Evaluation of the esthetic results of conservative treatment of breast cancer. in Tumori / Tumori. 1993 Aug 31;79(4):258-61. doi: 10.1177/030089169307900406.

1993
ASL Biella

Ciambellotti E; Moro G;

[Course of the serum determination of 4 tumor markers in viral hepatitis]. in Minerva medica / Minerva Med. 1987 Nov 15;78(21):1577-81.

1987
ASL Biella

Coda C; Lanza E; Ciambellotti E; Cartia GL; Moro G;

[Malignant tumors preceding or following breast cancer]. in Minerva medica / Minerva Med. 1985 Feb 11;76(5):185-92.

1985
ASL Biella

Coda C; Cartia GL; Moro G; Ciambellotti E;